Document is current

Any future updates will be listed below

Correction to: Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin

Crossref DOI link: https://doi.org/10.1186/s12933-017-0608-5

Published Online: 2017-11-13

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark